A complete manufacturing and material records review for the cphv valve r5-019 has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Since limited information is available, the definitive root cause of the reported event cannot be established at this time.However, from the document review performed, no manufacturing deficiencies were noted.Based on the information available, r5-019 was replaced with a larger valve r5-023.As such, the cause of the reported event can reasonably be related to mis-sizing.Should further information be received in the future, a follow up report will be provided.H3 other text: not available for return.
|
On (b)(6) 2023, a carbomedics reduced aortic valve r5-019 was implanted in a patient.As reported, the "condition was not good", so the valve was explanted and replaced with a larger valve r5-023 during the same day.The patient is doing well.Based on the further information received, the patient got better and has no problem anymore.The manufacturer was informed that no further information will be provided.
|